SGH
CYTR

Schonfeld Group Holdings’s CytRx Corp CYTR Stock Holding History

Schonfeld Group Holdings’s Portfolio CYTR Stock Details CYTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-10,033
Closed -$210K – 497
2014
Q1 		$210K Buy
+10,033
New +$356K 0.05% 485

Other funds holding CYTR

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Schonfeld Group Holdings's CYTR Position: Q2 2014 in Review

Schonfeld Group Holdings sold out of CytRx Corp (CYTR) in Q2 2014, closing a stake of 10,033 shares — an estimated $210K sold.

Schonfeld Group Holdings first reported a position in CYTR in Q1 2014 and held it in 1 quarter. The position peaked at $210K in Q1 2014. 74 funds tracked by Wall St. Rank hold CYTR as of Q2 2014.

  • Schonfeld Group Holdings reported no remaining CytRx Corp position as of Q2 2014 after selling out during the quarter.
  • Schonfeld Group Holdings sold 10,033 CytRx Corp shares in Q2 2014, an estimated $210K.
  • Schonfeld Group Holdings first reported a position in CytRx Corp in Q1 2014 and held it in 1 quarter.
  • Schonfeld Group Holdings's CytRx Corp position peaked at $210K in Q1 2014.
  • 74 funds tracked by Wall St. Rank held CytRx Corp as of Q2 2014.

Based on Schonfeld Group Holdings's 13F filing for Q2 2014, filed 15 Aug 2014.